|
| 36749630 | The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. | | 2023 |
| 35978049 | A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3. | Cell Death and Differentiation | 2023 |
| 37667220 | TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway. | | 2023 |
| 36711781 | TGFB1 Induces Fetal Reprogramming and Enhances Intestinal Regeneration. | bioRxiv | 2023 |
| 36575793 | Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases. | | 2023 |
| 37461034 | Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB/IIIC colon cancer: study protocol for a multicentre, randomized controlled trial. | | 2023 |
| 36702816 | Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors. | Cell Death Dis | 2023 |
| 34843402 | <i>TP53</i> Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer. | J Clin Oncol | 2022 |
| 35837159 | Survival and prognostic factors for postoperative primary appendiceal cancer: a retrospective cohort study based on the Surveillance, Epidemiology, and End Results database. | Journal of Gastrointestinal Oncology | 2022 |
| 35440095 | Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis. | Cell Death Dis | 2022 |
| 36336841 | Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3). | Cancer Communications | 2022 |
| 36209353 | N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. | Cancer Communications | 2022 |
| 36131281 | Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy. | Cell Communication and Signaling | 2022 |
| 35981499 | Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity. | Blood | 2022 |
| 36410171 | LncRNA HCG18 promotes M2 macrophage polarization to accelerate cetuximab resistance in colorectal cancer through regulating miR-365a-3p/FOXO1/CSF-1 axis. | Pathology Research and Practice | 2022 |
| 36518767 | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation. | | 2022 |
| 36467341 | Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis. | Ann Transl Med | 2022 |
| 36536137 | Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer. | | 2022 |
| 36660664 | Advances in adoptive cellular therapy for colorectal cancer: a narrative review. | | 2022 |
| 34434169 | Case Report: Successful Control of Pulmonary Metastatic Pheochromocytoma With Iodine-125 Seed Implantation. | Frontiers in Endocrinology | 2021 |
| 34179310 | Tumor suppressor p53 cross-talks with TRIM family proteins. | Genes and Diseases | 2021 |
| 34079082 | GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion. | Oncogene | 2021 |
| 33632217 | Correction to: A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. | Molecular Cancer | 2021 |
| 33681231 | The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer. | Frontiers in Cell and Developmental Biology | 2021 |
| 34266914 | Hypothermia Is a Potential New Therapy for a Subset of Tumors with Mutant p53. | Cancer Research | 2021 |
| 34044655 | Clinical characteristics and prognostic value of the <i>KRAS</i> mutation in Chinese colorectal cancer patients. | Int J Biol Markers | 2021 |
| 34099671 | Tumor suppressor p53 regulates intestinal type 2 immunity. | Nature Communications | 2021 |
| 33442424 | Combined assay of Circulating Tumor DNA and Protein Biomarkers for early noninvasive detection and prognosis of Non-Small Cell Lung Cancer. | Journal of Cancer | 2021 |
| 34249455 | Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015. | American Journal of Cancer Research (discontinued) | 2021 |
| 33495421 | The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of . | Aging | 2021 |
| 33259884 | The emerging role of leukemia inhibitory factor in cancer and therapy. | Pharmacology and Therapeutics | 2021 |
| 34657511 | Hepatic Artery Infusion Pump Combined With Systemic Chemotherapy for Patients With Liver Metastases From Breast Carcinoma. | Technology in Cancer Research and Treatment | 2021 |
| 32719388 | LIF is essential for ISC function and protects against radiation-induced gastrointestinal syndrome. | Cell Death and Disease | 2020 |
| 32193353 | Autophagy promotes mammalian survival by suppressing oxidative stress and p53. | Genes and Development | 2020 |
| 32394229 | Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer. | Cancer Causes and Control | 2020 |
| 32221559 | EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling. | Journal of Molecular Cell Biology | 2020 |
| 32275841 | Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis. | Cell Cycle | 2020 |
| 32478681 | Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression. | J Clin Invest | 2020 |
| 33376133 | Genetic and stochastic influences upon tumor formation and tumor types in Li-Fraumeni mouse models. | Life Sci Alliance | 2020 |
| 32686657 | Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration. | JCI insight | 2020 |
| 33182266 | The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway. | International Journal of Molecular Sciences | 2020 |
| 32722796 | Gain-of-function mutant p53 in cancer progression and therapy. | Journal of Molecular Cell Biology | 2020 |
| 31497032 | The Identification and Analysis of mRNA-lncRNA-miRNA Cliques From the Integrative Network of Ovarian Cancer. | Frontiers in Genetics | 2019 |
| 31619231 | Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report. | BMC Medical Genomics | 2019 |
| 30500901 | Tumor suppressor p53 and metabolism. | Journal of Molecular Cell Biology | 2019 |
| 30799283 | miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid Leukemia via Targeting Erbin. | Molecular Therapy | 2019 |
| 31153587 | Prognostic significance of resident CD103CD8T cells in human colorectal cancer tissues. | Acta Histochemica | 2019 |
| 31109967 | Hsa_circ_0009361 acts as the sponge of miR-582 to suppress colorectal cancer progression by regulating APC2 expression. | Clinical Science | 2019 |
| 31310660 | The role of p53 in reproduction, an unexpected function for a tumor suppressor. | Journal of Molecular Cell Biology | 2019 |
| 29587790 | Inhibition of HIV early replication by the p53 and its downstream gene p21. | Virology Journal | 2018 |